Fourier is a semiconductor company. They design a complex structure digital-analog hybrid chip. They provide products that include car audio amplifiers, mid and high-power audio amplifiers, smart audio amplifiers, SPC audio amplifiers, haptic drivers, power management, and more.
Private Equity Round in 2022
CanSemi is a chip manufacturing plant that manufactures microprocessors, power management chips, analog chips, and power discrete devices.
Private Equity Round in 2022
Developer and manufacturer of protectors, controllers, driver and current sensors. The company develops and manufactures motor sensor protectors, BMS current sensors, motor controllers, drives, and frequency inverters, providing high quality products and services to various industries including motors, household appliances, new energy, and automobiles.
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.
Chengdu Genevector Biotechnology Co., Ltd. (Genevector, Genevector) is a biotechnology company engaged in the research and development of new drugs for adeno-associated virus (AAV) gene therapy. The company is committed to the development of new AAV gene therapy drugs for ophthalmic diseases, neuromuscular diseases, genetic and metabolic diseases, etc.
Cloudbreak Therapeutics LLC is a clinical-stage biotechnology company based in Irvine, California, focused on developing ocular drugs for conditions such as glaucoma and pterygium. Founded in 2015, the company utilizes a capital-efficient business model that repurposes approved systemic drugs for ocular delivery. By prioritizing the rapid advancement of drug candidates through proof-of-concept Phase II clinical trials, Cloudbreak Therapeutics aims to out-license global rights for Phase III trials, product registration, and commercialization. The company strategically collaborates with contract research organizations to manage non-clinical, chemistry, manufacturing, and clinical development, thus maximizing its resources for effective drug development.
Chengmandian is a comprehensive provider of lithium battery energy solutions, specializing in the full life cycle management of lithium batteries. The company offers a range of services including charging, maintenance, leasing, replacement, and secondary utilization, emphasizing safe and efficient energy consumption. Chengmandian aims to innovate the application of lithium battery technology across various sectors such as shared motorcycles, battery swap systems, express delivery, and automotive industries. By focusing on digital operations and professional battery management, the company seeks to enhance energy recycling and operational efficiency, catering to both businesses and end consumers.
Aoxion Technology is a high-tech enterprise with core handwriting AI recognition technology, committed to providing full-scene digital solutions for judicial evidence for government, enterprise and public institutions. Based on the new generation of information technology such as big data, artificial intelligence, cloud computing, and blockchain, the company provides customers with a four-in-one full-stack signing service of "digital certificate and smart signing", which fully empowers paper documents electronically and electronically. Documents are digitized and data archives are evidenced to solve the last piece of paper in the digital society.
UnionTech 3D specializes in stereolithography 3D printing, an additive manufacturing technology that enables the production of highly precise and detailed polymer parts. The company develops industrial-grade 3D printers tailored for various sectors, including manufacturing, automotive, aerospace, and medical industries. In addition to manufacturing equipment, UnionTech 3D emphasizes research and development to enhance its product offerings. The company also provides technical support to facilitate the integration of 3D printing into industrial production processes.
Greatpower Technology specializes in the development and manufacturing of key materials for power batteries, particularly focusing on nickel sulphate, which is essential for lithium-ion batteries used in electric vehicles. The company is committed to advancing research and development in new energy resources and technologies. In addition to nickel sulphate, Greatpower produces other battery materials, including ternary precursors and lithium battery cathode materials. This approach not only enhances battery recycling efforts but also contributes to the establishment of a sustainable ecosystem within the new energy power battery industry.
Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizes cloud intelligent dispatching management, 4G.
Private Equity Round in 2021
Beijing Health Guard Biotechnology is a Beijing-based research and development company that focuses on the development of recombinant protein drugs and vaccines. Founded in 2008, the company specializes in creating novel biopharmaceuticals using a structure-guided design approach. Its primary area of expertise lies in the research and industrialization of recombinant protein vaccines, particularly for human papillomavirus (HPV). Beijing Health Guard Biotechnology is advancing multiple innovative candidate vaccines targeting various infectious diseases, with its core products including both trivalent and nonavalent HPV vaccines.
Berry Oncology is a medical technology company focused on enhancing cancer prevention and diagnosis through advanced genomic testing solutions. The company offers a range of products and services, including genetic diagnosis, companion diagnostics, and tools for monitoring treatment response and prognosis prediction for various malignant tumors. By addressing clinical challenges associated with cancer detection and management, Berry Oncology aims to facilitate early diagnosis and treatment, ultimately improving patient quality of life and reducing cancer risks. Its mission emphasizes precise treatment for all patients, while its vision seeks to establish the company as a leader in early screening and diagnosis within the global market, particularly in China's tumor gene testing sector.
JOINN Biologics is a California Bay Area-based company that is committed to the advancement of biotech and biopharmaceutics through our premier contract manufacturing and development services for biologics and advanced therapies. A vital part of the JOINN Family's successful 20+ year track record of supporting drug discovery and development, we provide a complete range of CDMO services, from early development to clinical manufacturing, for our clients and partners on a global scale. Core Capabilities • Molecular/developability assessment • cGMP clinical trial materials production • Commercial-scale cGMP manufacturing • Non-GMP protein expression and purification • Cell line development • Upstream process development • Downstream purification development • Analytical and formulation development • Documentation and reporting to support regulatory filings Mission It is our mission to provide our global clients and partners with a complete range of premier contract development and manufacturing services for biologics and advanced therapies, from early custom development to clinical manufacturing, to further accelerate the development of high-quality biologics, meeting patients' needs and delivering long-lasting value to the biotech and biopharmaceutical industry.
Private Equity Round in 2021
Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform. After users place orders on the mobile app, drugs will be delivered to their homes within half an hour.
Jiangsu Simcere Pharmaceutical Company, Ltd. is a prominent manufacturer and distributor of pharmaceutical products in China, specializing in a wide range of medications for conditions such as cancer, infections, arthritis, and digestive issues. Founded in 1995 and based in Nanjing, the company has transitioned from a distributor to a leading player in the pharmaceutical market, operating five GMP-certified manufacturing facilities and a dedicated research and development center. Simcere's product portfolio includes various formulations, such as recombinant human endostatin for advanced lung cancer, edaravone for acute cerebral infarction, and multiple amoxicillin formulations for infections. The company also addresses diverse therapeutic areas, including anti-allergic, anti-osteoporosis, and cardiovascular treatments. With strategic partnerships with notable firms, Simcere employs over 4,000 personnel and continues to expand its impact in the pharmaceutical sector.
Developer of detection reagents designed for gene testing. The company develops a capillary electrophoresis sequencing platform, a high throughput sequencing platform and a fluorescent quantitative detection platform to research and develop detection reagents, enabling clinical, forensic, biomedical and agricultural and animal husbandry institutions to have high quality gene testing products.
MicuRx discovers and develops novel antibiotics to combat drug resistant bacterial infections. Founded in 2007, MicuRx employs a hybrid U.S./China business model to capitalize on the global opportunities afforded by U.S. research and development coupled with the high-quality, cost-efficient infrastructure and scientific resources available in China. This hybrid business model enables MicuRx to implement an accelerated global development strategy with a goal of completing Phase II trials for its drug candidates in both the United States and China.
Denovo Biopharma is a privately held biotechnology company based in Hangzhou, China, specializing in biopharmaceuticals. The company offers a unique biomarker solution aimed at personalizing drug development. Its core technology is the first platform and algorithm designed for de novo genomic biomarker discovery, utilizing archived clinical samples to identify biomarkers that correlate with patient responsiveness to drug candidates. This capability is particularly beneficial for late-stage clinical drugs that have previously shown unsatisfactory efficacy. By enabling the identification of relevant biomarkers retrospectively, Denovo Biopharma assists biotech and pharmaceutical companies in designing new clinical trials targeted at specific patient populations, ultimately aiming to enhance drug efficacy and reduce adverse effects. The company's platform has broad applications across various therapeutic areas, including oncology, metabolic disorders, cardiology, immunology, and neurology.
Shandong Qihe Biotechnology Co., Ltd. produces, processes, and sells edible mushrooms. The company offers shiitake mushroom spawns, oyster mushroom logs, and oyster mushroom spawn. It engages in research and development of edible fungi products. Shandong Qihe Biotechnology Co., Ltd. was founded in 2000 and is headquartered in Zibo, China.
WM Motor Technology Co., Ltd., founded in 2015 and based in Shanghai, China, specializes in the design, development, and manufacture of electric vehicles. The company focuses on creating energy-efficient and battery-operated vehicles, offering innovative travel solutions to its customers. WM Motor emphasizes the integration of advanced technologies in its products, featuring the Living Motion electric powertrain, Living Pilot intelligent driving assistance system, and Living Engine operating system. These technologies provide enhanced connectivity and interactive capabilities, contributing to the efficiency and intelligence of its smart vehicle offerings.
Adlai Nortye Biopharma Co., Ltd. is a biopharmaceutical company based in Hangzhou, China, focused on the research and development of innovative treatments for cancer and metabolic diseases. Founded in 2004 and formerly known as Sinopep Pharmaceutical Inc., the company has shifted its emphasis to oncology and immuno-oncology. Adlai Nortye is committed to improving patient outcomes through the discovery and commercialization of differentiated medicines. With a solid foundation in peptide and protein drug development, the company has broadened its scope to include small molecules and therapeutic antibodies. It holds 23 granted patents and has published 7 PCT applications. Through strategic collaborations with global partners, Adlai Nortye has established a diverse pipeline of programs ranging from early pre-clinical stages to those ready for phase 3 clinical trials.
Shanghai Hanyu Medical Technology Co., Ltd. specializes in the research and development of medical devices aimed at treating heart valve diseases. Established in 2016 and headquartered in Shanghai, with an additional office in Beijing, the company is recognized as one of the pioneering domestic firms in the development, production, and sale of transcatheter mitral valve repair devices. Hanyu Medical's flagship product, ValveClamp, is designed for minimally invasive interventions to address mitral valve regurgitation, enabling surgeons to close heart valves efficiently during procedures.
Asieris Pharmaceuticals Co. Ltd. is a Chinese biotechnology company established in 2010 and headquartered in Taizhou, China. The company specializes in the research and development of pharmaceutical products aimed at treating tumors and addressing multidrug-resistant infections. Asieris focuses on innovative therapies within the oncology sector and is dedicated to combating the challenges posed by drug-resistant pathogens.
EOC Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. The company specializes in developing, manufacturing, and commercializing innovative oncology products, utilizing a licensing model to enhance its product pipeline. EOC partners with global biopharmaceutical firms to integrate their molecules into its local manufacturing and regulatory frameworks. The company currently has a pipeline of seven novel products, four of which have received Class I innovative drug approvals and are undergoing clinical studies in China. EOC operates an 8,000 square meter cGMP manufacturing facility in Taizhou, China Medical City, and maintains offices in major cities, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team experienced in pharmaceutical research and development, EOC aims to position itself as a leader in oncology innovation within China.
EOC Group is a biopharmaceutical company based in Shanghai, China, founded in 2015. The company specializes in developing, manufacturing, and commercializing innovative oncology products, utilizing a licensing model to enhance its product pipeline. EOC partners with global biopharmaceutical firms to integrate their molecules into its local manufacturing and regulatory frameworks. The company currently has a pipeline of seven novel products, four of which have received Class I innovative drug approvals and are undergoing clinical studies in China. EOC operates an 8,000 square meter cGMP manufacturing facility in Taizhou, China Medical City, and maintains offices in major cities, including Shanghai, Beijing, Hong Kong, and Los Angeles. With a team experienced in pharmaceutical research and development, EOC aims to position itself as a leader in oncology innovation within China.
Private Equity Round in 2019
Phylion Battery, based in Suzhou, China, specializes in the development, production, and sales of lithium-ion batteries, utilizing lithium manganate as the positive electrode material. The company has an annual production capacity of 5GWh and is recognized as a leading high-tech enterprise in the power lithium battery sector. With 15 years of successful technology transformation, Phylion has served 8 million end users and over 45,000 electric vehicles globally, providing power supply solutions for new energy vehicles and various industrial projects. In addition to manufacturing, Phylion is involved in related research and development activities in the energy storage sector.
Hunan Voc Acoustic Technology Co., Ltd. is a Chinese company specializing in the development, manufacture, and sale of acoustic products, including headphones, Bluetooth earphones, high-fidelity audio devices, and smart speakers. Founded in 2017 and based in Zhuzhou, the company engages in comprehensive acoustic technology services, integrating research and development with production and sales. Voc Acoustic Technology has entered the true wireless stereo (TWS) headset market and offers acoustic research and production services to brands globally, catering to both domestic and international clients.
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.
Heng Yi Biotechnology Co., Ltd. is a manufacturer of nutritional and dietary supplements based in Taichung, Taiwan, established in 1974. The company specializes in creating high-quality products using natural ingredients and raw materials. Its diverse product range includes food ingredients, essential oils, fragrances, beverages, confectionery items, organic products, healthcare products, pharmaceutical ingredients, and spray dry powder. Essential oils are available in various series, such as flower, plant, and fruit, while fragrances encompass a wide array of applications, including personal care and household products. Additionally, Heng Yi engages in the import and export of food raw materials, ensuring a strong presence in both domestic and international markets. The company is committed to maintaining stringent quality standards throughout the manufacturing, storage, distribution, and sales processes.
Shanghai Hanyu Medical Technology Co., Ltd. specializes in the research and development of medical devices aimed at treating heart valve diseases. Established in 2016 and headquartered in Shanghai, with an additional office in Beijing, the company is recognized as one of the pioneering domestic firms in the development, production, and sale of transcatheter mitral valve repair devices. Hanyu Medical's flagship product, ValveClamp, is designed for minimally invasive interventions to address mitral valve regurgitation, enabling surgeons to close heart valves efficiently during procedures.
Shanghai Chunmi Electronic Technology Co., Ltd. is a manufacturer of smart kitchen appliances, established in 2013 and headquartered in Shanghai, China. The company specializes in the production of induction rice cookers and a variety of other kitchen appliances, including ovens and microwaves. Chunmi's products integrate Internet of Things (IoT) technology, allowing consumers to connect their appliances to a mobile application for real-time updates and control over the cooking process, enhancing the overall cooking experience.
Royole Corporation is a manufacturer and pioneer of advanced flexible displays and sensors, specializing in innovative products such as foldable smartphones, smart writing pads, wearables, and mobile theaters. The company offers a range of applications for its technology, catering to various sectors, including consumer electronics, automotive, computing, and media. Its product lineup includes the FlexPai smartphone, Flexible+ wearables, the RoWrite smart writing pad, and the Moon mobile theater, designed for enhanced user experiences. Founded in 2012 and headquartered in Fremont, California, with an additional office in Shenzhen, China, Royole also provides consulting services and has established a strategic partnership with JD.COM to enhance its distribution. The company aims to deliver tailored solutions across multiple industries, focusing on next-generation human-machine interfaces and flexible electronics applications.
Huizhou Yipeng Energy Technology Co., Ltd. is a manufacturer based in Huizhou, China, specializing in lithium-ion battery systems for plug-in hybrid and pure electric vehicles. Established in 2014, the company focuses on the development and marketing of innovative energy solutions to support the growing demand for electric mobility. Its products are designed to enhance the efficiency and performance of electric vehicles, contributing to the advancement of sustainable transportation technologies.
Health (Beijing) Medical Technology Co., Ltd., a one-stop service platform for medical equipment,
Weifang Kanghua Biotech Co., Ltd. manufactures bio chemical reagents, vitro diagnostic products, and medical equipment. Its products include rapid test kits include fertility tests, hepatitis, digestive tract, respiratory tract, infectious disease tests, tumor markers tests, prenatal and postnatal care tests, utinalysis reagent strip, and other rapid tests; dots kits include infectious disease tests, rheumatic disease tests, immunological infertility tests, respiratory tract tests and other tests; and elisa kits include blood screening tests, prenatal and postnatal care tests, sexually transmitted disease tests, rheumatic disease tests, immunological infertility tests, and hepatitis tests. The company was founded in 1996 and is based in Weifang, China.
Goldpro is one professional manufacturer and exporter of grinding media steel balls in China. Besides supplying different sizes of grinding steel balls, the company also provides other services, like developing new special steel balls according to the ore conditions for its customers.
Hi-Think Yondervision (Beijing) Tech Co Ltd is a provider of digital solutions for housing provident funds and banking And service operators, providing housing provident fund management agencies and banks across the country with information system-related software customization development, maintenance services, third-party product sales and integration, outsourcing services and other services across multiple scenarios. At present, the company's business mainly includes five sectors: digital provident fund, digital port, digital financial services, service outsourcing, and data intelligence services. It has always focused on the field of housing finance, providing high-qualitymore
Private Equity Round in 2017
Shanghai Sanyou Medical Co., Ltd. specializes in the research, development, manufacturing, and sale of orthopedic implants in China. The company offers a range of products under the Tytus and Sanyou brands, including spinal implants such as anterior cervical plates and thoracolumbar systems, as well as minimally invasive options. In addition to spinal products, Sanyou Medical produces trauma implants for various applications, including shoulder, elbow, hip, pelvis, knee, and wrist systems. Headquartered in the Medical Apparatus Garden of Zhangjiang Hi-Tech Park in Shanghai, the company emphasizes innovative therapies and has implemented a restructured management system to enhance its sustainability and value in the healthcare sector.
Suzhou Zelgen Biopharmaceuticals Co., Ltd. is a biopharmaceutical company based in Kunshan, China, that focuses on the research, development, manufacturing, and sale of innovative medications. Founded in 2009, Zelgen specializes in small molecule and recombinant protein drugs aimed at treating various types of cancers, including liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, and nasopharyngeal carcinomas, as well as hematologic diseases such as myelofibrosis. The company is dedicated to addressing unmet medical needs in the domestic market by providing high-quality, safe, and effective therapies that are also affordable. Zelgen aspires to establish itself as a leading player in the Chinese biopharmaceutical sector.
SMO ClinPlus Co., Ltd., founded in 2009 and based in Shanghai, China, specializes in clinical trials and site management organization (SMO) services. Formerly known as Prius (Shanghai) Pharmaceutical Technology Development Co., Ltd., the company rebranded in November 2016. SMO ClinPlus offers a range of services to both domestic and international pharmaceutical and medical device companies, as well as organizations involved in clinical research and development of health-related products. Its offerings include preliminary model establishment, plan preparation, initiation of clinical trial sites, on-site implementation, and comprehensive project management, ensuring effective execution and oversight of clinical trials.